biological regulation (GO:0065007) | 0.39 | 8 | EPCAM, SPINT2, MYO5B, NEUROG3, SLC26A3, GUCY2C, DGAT1, SLC9A3 |
single-organism process (GO:0044699) | 0.48 | 8 | EPCAM, SPINT2, MYO5B, NEUROG3, SLC26A3, GUCY2C, DGAT1, SLC9A3 |
cellular process (GO:0009987) | 0.26 | 6 | EPCAM, SPINT2, NEUROG3, SLC26A3, GUCY2C, DGAT1 |
single-organism cellular process (GO:0044763) | 0.65 | 6 | EPCAM, SPINT2, NEUROG3, SLC26A3, GUCY2C, DGAT1 |
regulation of biological process (GO:0050789) | 0.45 | 6 | EPCAM, SPINT2, SLC26A3, GUCY2C, NEUROG3, SLC9A3 |
regulation of cellular process (GO:0050794) | 0.5 | 5 | EPCAM, SPINT2, SLC26A3, NEUROG3, GUCY2C |
multicellular organismal process (GO:0032501) | 1.45 | 4 | SLC26A3, NEUROG3, MYO5B, DGAT1 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 4 | EPCAM, NEUROG3, SLC26A3, SPINT2 |
regulation of metabolic process (GO:0019222) | 1.02 | 4 | EPCAM, NEUROG3, SLC26A3, SPINT2 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 4 | EPCAM, NEUROG3, SLC26A3, SPINT2 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 4 | EPCAM, SPINT2, SLC26A3, NEUROG3 |
chemical homeostasis (GO:0048878) | 2.97 | 4 | SLC26A3, DGAT1, MYO5B, SLC9A3 |
homeostatic process (GO:0042592) | 2.61 | 4 | SLC26A3, DGAT1, MYO5B, SLC9A3 |
regulation of biological quality (GO:0065008) | 1.68 | 4 | SLC26A3, DGAT1, MYO5B, SLC9A3 |
localization (GO:0051179) | 1.4 | 4 | SLC26A3, DGAT1, MYO5B, SLC9A3 |
regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 3 | EPCAM, NEUROG3, SLC26A3 |
cellular biosynthetic process (GO:0044249) | 1.37 | 3 | NEUROG3, DGAT1, GUCY2C |
organic substance biosynthetic process (GO:1901576) | 1.34 | 3 | DGAT1, NEUROG3, GUCY2C |
establishment of localization (GO:0051234) | 1.48 | 3 | SLC26A3, SLC9A3, MYO5B |
cellular developmental process (GO:0048869) | 1.82 | 3 | EPCAM, NEUROG3, SLC26A3 |
regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 3 | EPCAM, NEUROG3, SLC26A3 |
organic substance metabolic process (GO:0071704) | 0.63 | 3 | DGAT1, NEUROG3, GUCY2C |
negative regulation of biological process (GO:0048519) | 1.33 | 3 | EPCAM, NEUROG3, SPINT2 |
regulation of gene expression (GO:0010468) | 1.37 | 3 | EPCAM, NEUROG3, SLC26A3 |
developmental process (GO:0032502) | 1.36 | 3 | EPCAM, NEUROG3, SLC26A3 |
regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 3 | EPCAM, NEUROG3, SLC26A3 |
transport (GO:0006810) | 1.51 | 3 | SLC26A3, SLC9A3, MYO5B |
regulation of biosynthetic process (GO:0009889) | 1.37 | 3 | EPCAM, NEUROG3, SLC26A3 |
regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 3 | EPCAM, NEUROG3, SLC26A3 |
biosynthetic process (GO:0009058) | 1.32 | 3 | DGAT1, NEUROG3, GUCY2C |
regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 3 | EPCAM, NEUROG3, SLC26A3 |
metabolic process (GO:0008152) | 0.58 | 3 | NEUROG3, DGAT1, GUCY2C |
regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 3 | EPCAM, NEUROG3, SLC26A3 |
response to chemical (GO:0042221) | 1.98 | 3 | GUCY2C, SLC26A3, SLC9A3 |
regulation of localization (GO:0032879) | 1.94 | 3 | EPCAM, SPINT2, SLC9A3 |
primary metabolic process (GO:0044238) | 0.69 | 3 | NEUROG3, DGAT1, GUCY2C |
single-multicellular organism process (GO:0044707) | 1.78 | 3 | DGAT1, MYO5B, NEUROG3 |
response to stimulus (GO:0050896) | 1.22 | 3 | GUCY2C, SLC26A3, SLC9A3 |
regulation of RNA metabolic process (GO:0051252) | 1.52 | 3 | EPCAM, NEUROG3, SLC26A3 |
cellular metabolic process (GO:0044237) | 0.69 | 3 | DGAT1, NEUROG3, GUCY2C |
regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 3 | EPCAM, NEUROG3, SLC26A3 |
regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 3 | EPCAM, NEUROG3, SLC26A3 |
negative regulation of cellular process (GO:0048523) | 1.41 | 3 | EPCAM, SPINT2, NEUROG3 |
positive regulation of nucleic acid-templated transcription (GO:1903508) | 2.56 | 2 | EPCAM, NEUROG3 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 2 | NEUROG3, SPINT2 |
positive regulation of metabolic process (GO:0009893) | 1.74 | 2 | EPCAM, NEUROG3 |
positive regulation of biosynthetic process (GO:0009891) | 2.29 | 2 | EPCAM, NEUROG3 |
regulation of cell adhesion (GO:0030155) | 3.27 | 2 | EPCAM, SPINT2 |
cell differentiation (GO:0030154) | 2.14 | 2 | EPCAM, NEUROG3 |
regulation of cell-cell adhesion (GO:0022407) | 3.79 | 2 | EPCAM, SPINT2 |
negative regulation of cell adhesion (GO:0007162) | 4.33 | 2 | EPCAM, SPINT2 |
positive regulation of gene expression (GO:0010628) | 2.35 | 2 | EPCAM, NEUROG3 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 2 | NEUROG3, GUCY2C |
signal transduction (GO:0007165) | 1.28 | 2 | EPCAM, GUCY2C |
inorganic ion homeostasis (GO:0098771) | 3.43 | 2 | SLC9A3, SLC26A3 |
organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 2 | NEUROG3, GUCY2C |
negative regulation of cell-cell adhesion (GO:0022408) | 4.84 | 2 | EPCAM, SPINT2 |
response to endogenous stimulus (GO:0009719) | 2.79 | 2 | SLC9A3, SLC26A3 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 2 | NEUROG3, GUCY2C |
single-organism metabolic process (GO:0044710) | 1.63 | 2 | DGAT1, GUCY2C |
single-organism biosynthetic process (GO:0044711) | 2.8 | 2 | DGAT1, GUCY2C |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 2 | NEUROG3, SPINT2 |
positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | EPCAM, NEUROG3 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 2 | NEUROG3, GUCY2C |
cation homeostasis (GO:0055080) | 3.46 | 2 | SLC9A3, SLC26A3 |
regulation of pH (GO:0006885) | 5.24 | 2 | SLC9A3, SLC26A3 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | NEUROG3, GUCY2C |
positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 2 | EPCAM, NEUROG3 |
transmembrane transport (GO:0055085) | 2.72 | 2 | SLC9A3, SLC26A3 |
response to organic cyclic compound (GO:0014070) | 3.07 | 2 | SLC9A3, SLC26A3 |
positive regulation of transcription, DNA-templated (GO:0045893) | 2.56 | 2 | EPCAM, NEUROG3 |
organic substance transport (GO:0071702) | 2.15 | 2 | SLC26A3, MYO5B |
positive regulation of biological process (GO:0048518) | 1.2 | 2 | EPCAM, NEUROG3 |
positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 2.81 | 2 | EPCAM, NEUROG3 |
regulation of molecular function (GO:0065009) | 1.78 | 2 | SPINT2, NEUROG3 |
system process (GO:0003008) | 2.3 | 2 | SLC26A3, MYO5B |
ion homeostasis (GO:0050801) | 3.42 | 2 | SLC9A3, SLC26A3 |
heterocycle biosynthetic process (GO:0018130) | 1.7 | 2 | NEUROG3, GUCY2C |
regulation of cell proliferation (GO:0042127) | 2.41 | 2 | EPCAM, GUCY2C |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | SPINT2, NEUROG3 |
positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 2 | EPCAM, NEUROG3 |
ion transport (GO:0006811) | 2.66 | 2 | SLC9A3, SLC26A3 |
inorganic ion transmembrane transport (GO:0098660) | 3.38 | 2 | SLC9A3, SLC26A3 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 2 | NEUROG3, GUCY2C |
single-organism developmental process (GO:0044767) | 1.49 | 2 | NEUROG3, SLC26A3 |
ion transmembrane transport (GO:0034220) | 3.08 | 2 | SLC9A3, SLC26A3 |
single-organism transport (GO:0044765) | 2.18 | 2 | SLC9A3, SLC26A3 |
regulation of cellular component movement (GO:0051270) | 3.08 | 2 | EPCAM, SPINT2 |
monovalent inorganic cation homeostasis (GO:0055067) | 4.93 | 2 | SLC9A3, SLC26A3 |
positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 2 | EPCAM, NEUROG3 |
nucleobase-containing compound biosynthetic process (GO:0034654) | 1.72 | 2 | NEUROG3, GUCY2C |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 2 | NEUROG3, GUCY2C |
response to organic substance (GO:0010033) | 2.2 | 2 | SLC9A3, SLC26A3 |
single-organism localization (GO:1902578) | 2.09 | 2 | SLC9A3, SLC26A3 |
heterocycle metabolic process (GO:0046483) | 1.31 | 2 | NEUROG3, GUCY2C |
regulation of locomotion (GO:0040012) | 3.12 | 2 | EPCAM, SPINT2 |
cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 2 | NEUROG3, GUCY2C |
vesicle-mediated transport (GO:0016192) | 2.72 | 2 | SLC9A3, MYO5B |
anatomical structure development (GO:0048856) | 1.58 | 2 | EPCAM, NEUROG3 |
positive regulation of RNA metabolic process (GO:0051254) | 2.51 | 2 | EPCAM, NEUROG3 |
positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | EPCAM, NEUROG3 |
macromolecule metabolic process (GO:0043170) | 0.83 | 2 | NEUROG3, GUCY2C |
positive regulation of RNA biosynthetic process (GO:1902680) | 2.54 | 2 | EPCAM, NEUROG3 |
positive regulation of macromolecule biosynthetic process (GO:0010557) | 2.39 | 2 | EPCAM, NEUROG3 |
regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 2 | EPCAM, NEUROG3 |
regulation of cell motility (GO:2000145) | 3.16 | 2 | EPCAM, SPINT2 |
aromatic compound biosynthetic process (GO:0019438) | 1.7 | 2 | NEUROG3, GUCY2C |
positive regulation of cellular process (GO:0048522) | 1.3 | 2 | EPCAM, NEUROG3 |
small molecule metabolic process (GO:0044281) | 2.38 | 2 | DGAT1, GUCY2C |